CSF1 and breast carcinoma: The relevance of ERK1/2 in CSF-1R signaling was highlighted by the fact that enhancement of ERK1/2 phosphorylation upon CSF-1 treatment was found in 10 out of 17 breast cancer cell lines (Figure S2).